Health Sciences Authority (Singapore)

hsa.gov.sg Imported from official source

Regulator in Singapore; safety publications from its own official source.

Publications 44

  1. Recall of Fucithalmic Eye Drops 1% (fusidic acid)

    Retail-level recall of one batch of Fucithalmic Eye Drops 1% (SIN00726P), due to suspected aseptic process simulation failure

    Announcement Safety
  2. Recall of Farganesse Injection 50mg/2ml (promethazine)

    Retail-level recall of four batches of Farganesse Injection 50mg/2ml, containing promethazine due to presence of particles in the ampoules.

    Announcement Safety 2 versions
  3. Regulatory Updates (16 Nov 2026)

    As part of HSA’s ongoing efforts to enhance regulatory clarity and improve regulatory processes, the Medicinal Products Cluster is pleased to share the following updates with industry stakeholders:

    Announcement Safety
  4. Recall of Meravo Film-coated Tablet 100mg (sacubitril, valsartan)

    Retail-level recall of one batch of Meravo Film-coated Tablet 100mg (SIN16873P), due to out-of-specification results in stability study

    Announcement Safety 2 versions
  5. Recall of Agelmin Tablet 10 mg (cetirizine)

    Retail-level recall of one batch of AGELMIN TABLET 10 mg due to failed dissolution test results.

    Announcement Safety 2 versions
  6. Recall of Tetrabenazine 25mg 112’s Sun-Italy

    Retail-level recall of one batch of Tetrabenazine 25mg 112’s Sun-Italy, containing tetrabenazine, due to presence of black spots on the tablets.

    Announcement Safety
  7. Mean applicant screening response time

    HSA’s target screening turn-around-time from the date of receipt of the application dossier to the date of acceptance or non-acceptance/withdrawal of the application (excluding applicant’s response...

    Announcement
  8. Recall of Dantrium 20 mg Powder for Solution for Injection (dantrolene)

    Retail-level recall of one batch of Dantrium 20 mg Powder for Solution for Injection, containing dantrolene, due to presence of visible foreign particulate matter in the vials.

    Announcement Safety 3 versions
  9. Recall of Clonotril (Clonazepam) 0.5 Tablet 0.5 mg

    Retail-level recall of several batches of Clonotril 0.5 Tablet 0.5 mg due to out-of-specification results in stability study

    Announcement Safety
  10. Slides, FAQ & Resources – Virtual Sharing Session (24 September 2026)

    HSA organised a zoom webinar on Concurrent Change Notification and Premarket Submission Checklist for Medical Device Product Registration on 24 September 2026.

    Announcement Safety
  11. Regulatory Updates for Therapeutic Product Registration

    As part of HSA’s ongoing initiative to improve regulatory efficiency and enhance clarity in our regulatory requirements and processes, Therapeutic Products Branch (TPB) is pleased to update industr...

    Announcement Safety
  12. NU SKIN ageLOC Dermatic Effects

    Retail-level recall of NU SKIN ageLOC Dermatic Effects (all batches) due to theophylline detected.

    Announcement Safety
  13. Medicube PDRN Pink Collagen Capsule Cream

    Retail-level recall of 2 batches of Medicube PDRN Pink Collagen Capsule Cream (Batch nos: 2E122I.2E117I and 2E191G.2E193G) due to Sudan IV detected.

    Announcement Safety
  14. Recall of Carbimazole 5 Tablet 5 mg

    Wholesale-level recall of Carbimazole 5 Tablet 5 mg, due to out-of-specification test results in stability study

    Announcement Safety
  15. Recall of Fludeoxyglocuose F-18 Injection 5 - 20mCi/ml

    Retail-level recall of Fludeoxyglocuose F-18 Injection 5 - 20mCi/ml, containing Fluoro-2-deoxy-d-glucose, due to a failed radiochemical purity quality control test.

    Announcement Safety
  16. Recall of B. Braun Ibuprofen Solution for Infusion 4mg/ml

    Retail-level recall of B. Braun Ibuprofen Solution for Infusion 4mg/ml, containing ibuprofen, due to out-of-specification test results for impurities during stability study.

    Announcement Safety
  17. Recall of Guardian Skin Relief Calamine Lotion (14 August 2026)

    Retail-level recall of one batch of Guardian Skin Relief Calamine Lotion due to out-of-specification level of cadmium content.

    Announcement Safety

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.